Does LEVOMILNACIPRAN Cause Muscular weakness? 140 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 140 reports of Muscular weakness have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 10.2% of all adverse event reports for LEVOMILNACIPRAN.
140
Reports of Muscular weakness with LEVOMILNACIPRAN
10.2%
of all LEVOMILNACIPRAN reports
134
Deaths
81
Hospitalizations
How Dangerous Is Muscular weakness From LEVOMILNACIPRAN?
Of the 140 reports, 134 (95.7%) resulted in death, 81 (57.9%) required hospitalization, and 82 (58.6%) were considered life-threatening.
Is Muscular weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 140 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOMILNACIPRAN Cause?
Off label use (376)
Drug ineffective (315)
Gastrooesophageal reflux disease (295)
Vomiting (294)
Hypoaesthesia (290)
Abdominal pain upper (285)
Paraesthesia (282)
Memory impairment (277)
Blepharospasm (276)
Taste disorder (276)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which LEVOMILNACIPRAN Alternatives Have Lower Muscular weakness Risk?
LEVOMILNACIPRAN vs LEVONORGESTREL
LEVOMILNACIPRAN vs LEVORPHANOL
LEVOMILNACIPRAN vs LEVOSIMENDAN
LEVOMILNACIPRAN vs LEVOSULPIRIDE
LEVOMILNACIPRAN vs LEVOTHYROXINE